Cite
HARVARD Citation
Gascon, P. et al. (n.d.). Treatment patterns and outcomes in the DLBCL cohort of a study (MONITOR‐GCSF) assessing biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropenia. Hematological oncology. p. 351. [Online].